<DOC>
	<DOCNO>NCT01568138</DOCNO>
	<brief_summary>The purpose study determine safety , feasibility device , enable LV volume radius reduction scar exclusion patient whose systolic HF due ischemic cardiomyopathy . Appropriate subject akinetic dyskinetic scar locate antero-septal LV distribution . Use device replicates geometric reconfiguration ventricle achieve surgical Left Ventricular Reconstruction ( LVR ) , beat , unsupported heart , thereby create option avoid use cardiopulmonary bypass pump ( CBP ) .</brief_summary>
	<brief_title>Prospective Study BioVentrix PliCath HF™ System Treatment Ischemic Cardiomyopathy</brief_title>
	<detailed_description>Congestive heart failure `` epidemic '' cardiovascular disease ( Eugene Braunwald , NEJM 1997 ) , yet cure . The American Heart Association ( AHA ) report nearly five million Americans afflict . Approximately 1.5 million admission US due heart failure ( HF ) ; number one cost-item Medicare , comprise 6 % total expenditure . In view limitation exist therapy , physician seek alternative treatment . In regard , longstanding interest surgical reconstruction fail heart . The underlying premise surgically reduce size ventricular chamber remove portion ventricular wall decrease chamber radius . A reduction chamber radius reduce wall stress give pressure remain muscle put favorable mechanical state . The BioVentrix PliCath HF System consist implantable anchor , delivery system , accessory , sterile biocompatible . These device use reconfiguration abnormal cardiac geometry cause dysfunction exclude portion leave ventricular chamber . The procedure base premise beneficial effect Left Ventricular Reconstruction ( LVR ) via radius volume reduction , realize exclude portion scar left ventricle wall circumference . The procedure similar Dor procedure except utilizes series anchor place Fontan stitch patch exclude infarcted tissue reduce size leave ventricle chamber scar leave ventricle wall . Because ventricle resect , possible procedure without cardiopulmonary bypass pump . The validity concept document . Geometric confirmation initially accomplish bench model , radius decrease 24 % volume diminish 35 % exclusion antero-septal wall segment dilate , explanted porcine heart . When use PliCath System accomplish LV reconfiguration , fundamental technical maneuver placement hollow needle predetermine site anterior wall scar , across LV chamber , predetermine site scar interventricular septum . Once achieve , flexible guidewire advance needle free right ventricular ( RV ) chamber . Once wire completely septum , dilator enables passage 14Fr Introducer traverse needle route , allow introduction internal , elongated anchor orient appropriate alignment match external anchor identical length alignment . The anchor , place RV epicardium result original needle passage , bring toward contact two wall establish appose along length . The action repeat ( i.e. , repeat needle stick anchor placement ) , along long axis LV linear portion antero-lateral wall contact correspond portion septum , exclude entire intervene wall segment circumference chamber . The device design allow removal stage deployment prior removal `` Leash '' attach hinge , internal anchor .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Age 18 80 15 % ≥ LVEF ≤ 45 % NYHA FC IIIII 60 cc/m² ≥ LVESV/I ≤ 120 cc/m² Acontractile ( akinetic and/or dyskinetic ) scar locate anteroseptalapical region due prior infarction evidence echocardiogram and/or MRI Maintained standard medical management least 90 day , stable target ( maximum tolerate ) dosage . Willing competent complete inform consent Viability myocardium region remote area intend scar exclusion evidence echocardiogram and/or MRI Agree require followup visit Calcified ventricular wall akinetic region Thrombus intraventricular mass leave atrium ventricle Cardiac Resynchronization Therapy ( CRT ) device placement within prior 60 day enrollment Significant diastolic dysfunction , define pseudonormal Doppler filling pattern E/A ratio &gt; 2 Thin wall , paradoxically move septal scar would preclude successful support anchor pair evidence MRI Cardiac valve disease , opinion investigator , require surgery Mitral Regurgitation &gt; 1+ Intolerance unwillingness take warfarin Functioning pacemaker lead anteroapical RV , opinion investigator , would interfere anchor placement . Pulmonary Arterial Pressure &gt; 60 mm Hg Myocardial Infarction within prior 90 day enrollment Previous CVA TIA result , opinion investigator , significant residual neurological deficit Comorbid disease process life expectancy le one year Patients lung , kidney and/or liver transplant Chronic renal failure serum creatinine &gt; 2 mg/dL Pregnant planning become pregnant study Enrolled concurrent study observational</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Ventricular Remodeling</keyword>
</DOC>